Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis

BACKGROUND: The angiotensin‐receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin‐converting enzyme inhibitor enalapril in terms of reducing cardiovascular mortality in the PARADIGM‐HF (Prospective Comparison of ARNI with angiotensin‐converting enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiwen, Zhou, Ran, Lu, Chi, Chen, Qing, Xu, Tongda, Li, Dongye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662364/
https://www.ncbi.nlm.nih.gov/pubmed/31240976
http://dx.doi.org/10.1161/JAHA.119.012272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662364/
https://www.ncbi.nlm.nih.gov/pubmed/31240976
http://dx.doi.org/10.1161/JAHA.119.012272

Ejemplares similares